Drug Delays Cost Millions of Dollars

Delays to an Indian company's generic versions of three blockbuster drugs are costing U.S. health-care payers millions of dollars—and preserving millions of dollars in revenue for the makers of the brand-name versions.



from WSJ.com: US Business http://ift.tt/1vAVeHY

via IFTTT